Disclosures for "Long-Term Efficacy of Fremanezumab in Patients with Chronic Migraine: a Systematic Review and Single-Arm Meta-Analysis"
-
Dr. Sahin has nothing to disclose.
-
Miss Makita has nothing to disclose.
-
Ms. Koppanatham has nothing to disclose.
-
Mr. Cruccioli has nothing to disclose.
-
Miss Campos has nothing to disclose.
-
Mr. Teixeira has nothing to disclose.
-
Dr. Gregorio Barbosa Tavares has nothing to disclose.